Clinical Trials Browser

Phase 2 × Terminated × Atrasentan × Clear all

NCT00653328 2012-05-23

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Phase 2 Terminated

15 enrolled 10 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms